Literature DB >> 21726542

Role of DNA damage in atherosclerosis--bystander or participant?

Kelly Gray1, Martin Bennett.   

Abstract

Atherosclerosis leading to cardiovascular disease is the leading cause of death among western populations. Atherosclerosis in characterised by the development of a fibrofatty lesion that consists of a diverse cell population, including inflammatory cells that create an intensely oxidising environment within the vessel. Coupled with normal replication, the local intracellular and extracellular environment causes damage to cellular DNA that is recognised and repaired by the DNA damage response (DDR) pathway. The role of DNA damage and the resulting deregulation of 'normal' cellular behaviour and subsequent loss of cell cycle control checkpoints have been widely studied in cancer. However, despite the extensive evidence for DNA damage in atherosclerosis, it is only over the past two decades that a causative link between DNA damage and atherosclerosis has been hypothesised. Whilst atherosclerosis is a feature of human disease characterised by defects in DNA damage, currently the role of DNA damage in the initiation and progression of atherosclerosis remains highly debated, as a 'chicken and egg' situation. This review will analyse the evidence for, the causes of, and consequences of DNA damage in atherosclerosis, detail the DNA damage response pathway that results in these consequences, and highlight therapeutic opportunities in this area. We also outline the evidence that DNA damage is a cause of both initiation and progression of atherosclerosis, and not just a consequence of disease.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21726542     DOI: 10.1016/j.bcp.2011.06.025

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  19 in total

1.  Can the DNA damage response be harnessed to modulate atherosclerotic plaque phenotype?

Authors:  Babak Razani; Elaine W Raines
Journal:  Circ Res       Date:  2015-02-27       Impact factor: 17.367

2.  Cell injury and repair resulting from sleep loss and sleep recovery in laboratory rats.

Authors:  Carol A Everson; Christopher J Henchen; Aniko Szabo; Neil Hogg
Journal:  Sleep       Date:  2014-12-01       Impact factor: 5.849

3.  MCPIP is induced by cholesterol and participated in cholesterol-caused DNA damage in HUVEC.

Authors:  Jingjing Da; Ming Zhuo; Minzhang Qian
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Association of oxidative DNA damage and C-reactive protein in women at risk for cardiovascular disease.

Authors:  Nicole Noren Hooten; Ngozi Ejiogu; Alan B Zonderman; Michele K Evans
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-13       Impact factor: 8.311

5.  DNA and chromosomal damage in peripheral blood lymphocytes in patients with acute coronary syndrome undergoing a coronary angiography.

Authors:  Jovana Tubic Vukajlovic; Ivan Simic; Olivera Milosevic-Djordjevic
Journal:  Anatol J Cardiol       Date:  2021-04       Impact factor: 1.596

6.  Nesprin-2-dependent ERK1/2 compartmentalisation regulates the DNA damage response in vascular smooth muscle cell ageing.

Authors:  D T Warren; T Tajsic; L J Porter; R M Minaisah; A Cobb; A Jacob; D Rajgor; Q P Zhang; C M Shanahan
Journal:  Cell Death Differ       Date:  2015-03-06       Impact factor: 15.828

7.  Poly(ADP-ribose) protects vascular smooth muscle cells from oxidative DNA damage.

Authors:  Chao Zhang; Tao Luo; Shijun Cui; Yongquan Gu; Chunjing Bian; Yibin Chen; Xiaochun Yu; Zhonggao Wang
Journal:  BMB Rep       Date:  2015-06       Impact factor: 4.778

8.  Computer-assisted ultrasound assessment of plaque characteristics in radiation-induced and non-radiation-induced carotid atherosclerosis.

Authors:  Yuanxi Li; Dora Lai-Wan Kwong; Vincent Wing-Cheung Wu; Shea-Ping Yip; Helen Ka-Wai Law; Shara Wee-Yee Lee; Michael Tin-Cheung Ying
Journal:  Quant Imaging Med Surg       Date:  2021-06

Review 9.  The Role of SGLT2 Inhibitors in Vascular Aging.

Authors:  Le Liu; Yu-Qing Ni; Jun-Kun Zhan; You-Shuo Liu
Journal:  Aging Dis       Date:  2021-08-01       Impact factor: 6.745

Review 10.  Preventive and therapeutic effects of MG132 by activating Nrf2-ARE signaling pathway on oxidative stress-induced cardiovascular and renal injury.

Authors:  Wenpeng Cui; Yang Bai; Ping Luo; Lining Miao; Lu Cai
Journal:  Oxid Med Cell Longev       Date:  2013-03-07       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.